This publication is an update of the 2005 guidelines for measuring national HIV prevalence in populationbased surveys of the UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. These guidelines are written for public health surveillance and programme officers responsible for monitoring the HIV epidemic ...

In Asia and the Pacific, an estimated 4.9 million people were living with HIV in 2012.  Although the rate of new HIV infections has decreased over the last decade, there are still an estimated 353 000 new infections each year in the region. HIV treatment ...

WHO guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection provide a public health approach for scaling up HIV care and treatment programmes and focus on simplified, harmonized and effective antiretroviral therapy (ART) regimens for use in resource-limited settings. In ...

Настоящее сводное руководство содержит новые рекомендации по диагностике инфекции, вызываемой вирусом иммунодефицита человека (ВИЧ), оказанию помощи людям, живущим с ВИЧ, и использованию антиретровирусных (АРВ) препаратов для лечения и профилактики ВИЧ-инфекции. Эти рекомендации касаются всех этапов оказания помощи при ВИЧ-инфекции, включая тестирование, уход и лечение. В ...

WHO guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection provide a public health approach for scaling up HIV care and treatment programmes and focus on simplified, harmonized and effective antiretroviral therapy (ART) regimens for use in resource-limited settings. In ...

The Prequalification of Medicines Programme (PQP) • A United Nations Programme managed by WHO • Started in March 2001 as a Pilot Project: Focus on HIV/AIDS • Partners included WHO, UNICEF, UNFPA, UNAIDS and supported by World Bank • Quickly expanded to include Tuberculosis, Malaria, Reproductive Health, Influenza and ...

This paper, intended as a resource for parliamentarians, is the result of long-standing, close collaboration between the Inter-Parliamentary Union (IPU) and the Joint United Nations Programme on HIV/AIDS (UNAIDS). IPU and UNAIDS hope it will inspire and help parliaments and parliamentarians everywhere take strong political ...

Despite decreases in the rate of spread in the last decade, the number of new HIV diagnoses in Europe continues to increase, and by 2011, reached over 1.2 million individuals, with over half a million diagnoses reported in the last five years. Between 2006 and ...

The paper provides information on the prices paid by 20 middle-income countries for adult and paediatric formulations of antiretroviral (ARV) drugs recommended by the World Health Organization (WHO). It links this information with an analysis of the intellectual property situation of the selected ARV medicines ...

How do intellectual property rights affect access to HIV medicines and other health technologies? This document provides a review of key issues related to intellectual property policies and their potential impact on access to HIV and other medicines. It is intended as an introduction to the ...